NCT04738357View on ClinicalTrials.gov

A Clinical Study to Evaluate Efficacy and Safety of HSK21542 for Postoperative Analgesia of Subjects Undergoing Elective Laparoscopic Surgery Under General Anesthesia

PHASE3CompletedINTERVENTIONAL

Enrollment

276

Participants

Timeline

Start Date

March 24, 2021

Primary Completion Date

July 30, 2021

Study Completion Date

September 30, 2021

Conditions

Postoperative Analgesia

Interventions

DRUG

HSK21542

HSK21542：1 µg/kg

DRUG

Placebo

Trial Locations (1)

Unknown

Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors

lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY

NCT04738357 - A Clinical Study to Evaluate Efficacy and Safety of HSK21542 for Postoperative Analgesia of Subjects Undergoing Elective Laparoscopic Surgery Under General Anesthesia | Biotech Hunter | Biotech Hunter